• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

硬脂酰辅酶 A 去饱和酶 (SCD) 通过增强雄激素受体转录激活促进前列腺癌细胞的增殖。

Stearoyl CoA desaturase (SCD) facilitates proliferation of prostate cancer cells through enhancement of androgen receptor transactivation.

机构信息

Department of Biological Sciences, College of Natural Sciences, Chonnam National University, Gwangju 500-757, Korea.

出版信息

Mol Cells. 2011 Apr;31(4):371-7. doi: 10.1007/s10059-011-0043-5. Epub 2011 Feb 10.

DOI:10.1007/s10059-011-0043-5
PMID:21331774
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3933960/
Abstract

Stearoyl-CoA desaturase (SCD), the rate-limiting enzyme in the biosynthesis of monounsaturated fatty acids, is highly expressed in prostate cancer although the SCD protein has been known to be rapidly turned over by proteolytic cleavage. The present data demonstrate that SCD can promote proliferation of androgen receptor (AR)-positive LNCaP prostate cancer cells and enhance dihydrotestosterone (DHT)-induced AR transcriptional activity, resulting in increased expression of prostate-specific antigen (PSA) and kallikrein-related peptidase 2 (KLK2). Interestingly, among the previously reported SCD-derived peptides produced by proteolytic cleavage of SCD, a peptide spanning amino acids 130-162 of SCD (SCD-CoRNR) contained the CoRNR box motif (LFLII) and enhanced AR transcriptional activity. In contrast, a mutant SCD-CoRNR in which Leu136 was replaced by Ala had no effect on AR transcriptional activity. Moreover, SCD-CoRNR directly interacted with AR and inhibited RIP140 suppression of AR transactivation. Knockdown of the SCD gene by SCD microRNA suppressed AR transactivation with decreased cell proliferation, suggesting that SCD may regulate the proliferation of LNCaP cells via modulation of AR transcriptional activity. Moreover, ectopic expression of SCD in LNCaP cells facilitated LNCaP tumor formation and growth in nude mice. Together, the data indicate that SCD plays a key role in the regulation of AR transcriptional activity in prostate cancer cells.

摘要

硬脂酰辅酶 A 去饱和酶(SCD)是单不饱和脂肪酸生物合成中的限速酶,尽管 SCD 蛋白已被证明会被蛋白水解切割迅速降解,但在前列腺癌中高度表达。本研究数据表明,SCD 可促进雄激素受体(AR)阳性 LNCaP 前列腺癌细胞的增殖,并增强二氢睾酮(DHT)诱导的 AR 转录活性,导致前列腺特异性抗原(PSA)和激肽释放酶相关肽 2(KLK2)的表达增加。有趣的是,在之前报道的 SCD 蛋白经蛋白水解切割产生的 SCD 衍生肽中,一段跨越 SCD 氨基酸 130-162 的肽(SCD-CoRNR)含有 CoRNR 盒基序(LFLII),并增强了 AR 转录活性。相比之下,将 Leu136 替换为 Ala 的突变 SCD-CoRNR 对 AR 转录活性没有影响。此外,SCD-CoRNR 直接与 AR 相互作用,并抑制 RIP140 对 AR 反式激活的抑制作用。SCD 微小 RNA 对 SCD 基因的敲低抑制了 AR 反式激活,同时降低了细胞增殖,这表明 SCD 可能通过调节 AR 转录活性来调节 LNCaP 细胞的增殖。此外,在 LNCaP 细胞中异位表达 SCD 促进了 LNCaP 肿瘤在裸鼠中的形成和生长。综上所述,数据表明 SCD 在前列腺癌细胞中 AR 转录活性的调节中发挥关键作用。

相似文献

1
Stearoyl CoA desaturase (SCD) facilitates proliferation of prostate cancer cells through enhancement of androgen receptor transactivation.硬脂酰辅酶 A 去饱和酶 (SCD) 通过增强雄激素受体转录激活促进前列腺癌细胞的增殖。
Mol Cells. 2011 Apr;31(4):371-7. doi: 10.1007/s10059-011-0043-5. Epub 2011 Feb 10.
2
Negative modulation of androgen receptor transcriptional activity by Daxx.Daxx对雄激素受体转录活性的负向调节
Mol Cell Biol. 2004 Dec;24(24):10529-41. doi: 10.1128/MCB.24.24.10529-10541.2004.
3
Changes in androgen receptor nongenotropic signaling correlate with transition of LNCaP cells to androgen independence.雄激素受体非基因组信号的变化与LNCaP细胞向雄激素非依赖性的转变相关。
Cancer Res. 2004 Oct 1;64(19):7156-68. doi: 10.1158/0008-5472.CAN-04-1121.
4
TGF-beta signaling and androgen receptor status determine apoptotic cross-talk in human prostate cancer cells.转化生长因子-β信号传导和雄激素受体状态决定了人类前列腺癌细胞中的凋亡串扰。
Prostate. 2008 Feb 15;68(3):287-95. doi: 10.1002/pros.20698.
5
Nrf1 and Nrf2 transcription factors regulate androgen receptor transactivation in prostate cancer cells.Nrf1和Nrf2转录因子调节前列腺癌细胞中的雄激素受体反式激活。
PLoS One. 2014 Jan 22;9(1):e87204. doi: 10.1371/journal.pone.0087204. eCollection 2014.
6
FUS/TLS is a co-activator of androgen receptor in prostate cancer cells.FUS/TLS 是前列腺癌细胞中雄激素受体的共激活因子。
PLoS One. 2011;6(9):e24197. doi: 10.1371/journal.pone.0024197. Epub 2011 Sep 1.
7
Comparison of prostate cancer cell lines for androgen receptor-mediated reporter gene assays.用于雄激素受体介导的报告基因检测的前列腺癌细胞系比较。
Toxicol In Vitro. 2006 Oct;20(7):1159-67. doi: 10.1016/j.tiv.2006.03.003. Epub 2006 Mar 8.
8
The tumor suppressor ING1b is a novel corepressor for the androgen receptor and induces cellular senescence in prostate cancer cells.肿瘤抑制因子ING1b是雄激素受体的一种新型共抑制因子,并可诱导前列腺癌细胞发生细胞衰老。
J Mol Cell Biol. 2016 Jun;8(3):207-20. doi: 10.1093/jmcb/mjw007. Epub 2016 Mar 18.
9
Activation of p300 histone acetyltransferase activity and acetylation of the androgen receptor by bombesin in prostate cancer cells.蛙皮素在前列腺癌细胞中激活p300组蛋白乙酰转移酶活性并使雄激素受体乙酰化。
Oncogene. 2006 Mar 30;25(14):2011-21. doi: 10.1038/sj.onc.1209231.
10
Tissue prostate-specific antigen facilitates refractory prostate tumor progression via enhancing ARA70-regulated androgen receptor transactivation.组织前列腺特异性抗原通过增强ARA70调节的雄激素受体反式激活促进难治性前列腺肿瘤进展。
Cancer Res. 2008 Sep 1;68(17):7110-9. doi: 10.1158/0008-5472.CAN-07-6507.

引用本文的文献

1
Characteristics and prognosis of central nervous system relapse after allogeneic hematopoietic stem cell transplantation in adult patients with leukemia.成年白血病患者异基因造血干细胞移植后中枢神经系统复发的特征及预后
Bone Marrow Transplant. 2025 Jul 17. doi: 10.1038/s41409-025-02673-4.
2
Targeting Stearoyl-CoA Desaturase 1 Through PI3K-AKT-mTOR Signaling in Head and Neck Squamous Cell Carcinoma.通过PI3K-AKT-mTOR信号通路靶向硬脂酰辅酶A去饱和酶1在头颈部鳞状细胞癌中的作用
OTO Open. 2025 Jun 19;9(2):e70143. doi: 10.1002/oto2.70143. eCollection 2025 Apr-Jun.
3
Alterations in Lipid Saturation Trigger Remodeling of the Outer Mitochondrial Membrane.脂质饱和度的改变引发线粒体外膜重塑。
bioRxiv. 2025 Jan 23:2025.01.20.633997. doi: 10.1101/2025.01.20.633997.
4
Adipose Tissues Have Been Overlooked as Players in Prostate Cancer Progression.脂肪组织在前列腺癌进展中被忽视了。
Int J Mol Sci. 2024 Nov 12;25(22):12137. doi: 10.3390/ijms252212137.
5
Comprehensive analysis of stearoyl-coenzyme A desaturase in prostate adenocarcinoma: insights into gene expression, immune microenvironment and tumor progression.前列腺腺癌中硬脂酰辅酶 A 去饱和酶的综合分析:基因表达、免疫微环境和肿瘤进展的见解。
Front Immunol. 2024 Sep 16;15:1460915. doi: 10.3389/fimmu.2024.1460915. eCollection 2024.
6
Identifying Key Genes as Progression Indicators of Prostate Cancer with Castration Resistance Based on Dynamic Network Biomarker Algorithm and Weighted Gene Correlation Network Analysis.基于动态网络生物标志物算法和加权基因共表达网络分析鉴定关键基因作为去势抵抗性前列腺癌进展的指标
Biomedicines. 2024 Sep 23;12(9):2157. doi: 10.3390/biomedicines12092157.
7
FADS2 confers SCD1 inhibition resistance to cancer cells by modulating the ER stress response.FADS2 通过调节内质网应激反应赋予癌细胞 SCD1 抑制抗性。
Sci Rep. 2024 Jun 7;14(1):13116. doi: 10.1038/s41598-024-64043-2.
8
Targeting Dysregulated Lipid Metabolism in Cancer with Pharmacological Inhibitors.使用药理学抑制剂靶向癌症中失调的脂质代谢
Cancers (Basel). 2024 Mar 28;16(7):1313. doi: 10.3390/cancers16071313.
9
Exploring the Influence of the Selected Conjugated Fatty Acids Isomers and Cancerous Process on the Fatty Acids Profile of Spleen.探索所选共轭脂肪酸异构体和癌变过程对脾脏脂肪酸谱的影响。
Cancers (Basel). 2024 Jan 23;16(3):479. doi: 10.3390/cancers16030479.
10
Unveiling the MUFA-Cancer Connection: Insights from Endogenous and Exogenous Perspectives.揭示 MUFA 与癌症的关联:内源性和外源性视角的洞察。
Int J Mol Sci. 2023 Jun 8;24(12):9921. doi: 10.3390/ijms24129921.

本文引用的文献

1
Abrogation of de novo lipogenesis by stearoyl-CoA desaturase 1 inhibition interferes with oncogenic signaling and blocks prostate cancer progression in mice.通过硬脂酰辅酶 A 去饱和酶 1 抑制作用废除从头脂肪生成会干扰致癌信号转导并阻止小鼠前列腺癌的进展。
Mol Cancer Ther. 2010 Jun;9(6):1740-54. doi: 10.1158/1535-7163.MCT-09-1064. Epub 2010 Jun 8.
2
Structural basis for nuclear receptor corepressor recruitment by antagonist-liganded androgen receptor.拮抗剂配体结合的雄激素受体募集核受体共抑制因子的结构基础。
Mol Cancer Ther. 2008 Oct;7(10):3187-94. doi: 10.1158/1535-7163.MCT-08-0461.
3
Tissue prostate-specific antigen facilitates refractory prostate tumor progression via enhancing ARA70-regulated androgen receptor transactivation.组织前列腺特异性抗原通过增强ARA70调节的雄激素受体反式激活促进难治性前列腺肿瘤进展。
Cancer Res. 2008 Sep 1;68(17):7110-9. doi: 10.1158/0008-5472.CAN-07-6507.
4
FXRalpha down-regulates LXRalpha signaling at the CETP promoter via a common element.法尼酯X受体α(FXRα)通过一个共同元件在胆固醇酯转运蛋白(CETP)启动子处下调肝X受体α(LXRα)信号传导。
Mol Cells. 2008 Oct 31;26(4):409-14. Epub 2008 Jun 18.
5
Fatty acid synthase and the lipogenic phenotype in cancer pathogenesis.脂肪酸合酶与癌症发病机制中的脂肪生成表型
Nat Rev Cancer. 2007 Oct;7(10):763-77. doi: 10.1038/nrc2222.
6
TR4 orphan nuclear receptor functions as an apoptosis modulator via regulation of Bcl-2 gene expression.TR4孤儿核受体通过调控Bcl-2基因表达发挥凋亡调节因子的作用。
Biochem Biophys Res Commun. 2007 Sep 21;361(2):323-8. doi: 10.1016/j.bbrc.2007.06.168. Epub 2007 Jul 10.
7
Estrogen receptors: how do they signal and what are their targets.雌激素受体:它们如何发出信号以及它们的靶点是什么。
Physiol Rev. 2007 Jul;87(3):905-31. doi: 10.1152/physrev.00026.2006.
8
Cancer statistics, 2007.2007年癌症统计数据。
CA Cancer J Clin. 2007 Jan-Feb;57(1):43-66. doi: 10.3322/canjclin.57.1.43.
9
Receptor-interacting protein 140 is a repressor of the androgen receptor activity.受体相互作用蛋白140是雄激素受体活性的一种抑制因子。
Mol Endocrinol. 2006 Jul;20(7):1506-18. doi: 10.1210/me.2005-0286. Epub 2006 Mar 9.
10
Membrane topology of mouse stearoyl-CoA desaturase 1.小鼠硬脂酰辅酶A去饱和酶1的膜拓扑结构
J Biol Chem. 2006 Jan 13;281(2):1251-60. doi: 10.1074/jbc.M508733200. Epub 2005 Nov 7.